4596 Share Price Performance
JP¥0
-46.00 (-100.00%)
Price JP¥0
Share Pricen/a
Kubota Pharmaceutical Holdings Co., Ltd. Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 0 Fair Values set on narratives written by author
4596 Community Narratives
There are no narratives available yet.
There are no community narratives available.
Trending Discussion
Recently Updated Narratives
No recently updated narratives available.
Snowflake Analysis
Kubota Pharmaceutical Holdings Co., Ltd. Key Details
Last Reported Earnings
Dec 31, 2025
Next Reporting Earnings
n/a
- -5.86
- -23.81%
- -3,219.05%
- 0%
About 4596
- Founded
- 2002
- Employees
- 8
- CEO
- WebsiteView website
Kubota Pharmaceutical Holdings Co., Ltd. develops portfolio of drugs and devices worldwide. The company offers eyeMO remote retinal monitoring device patient-based ophthalmology suite, that includes home-based miniature and NASA high-res version optical coherence tomography devices. Its product pipeline comprises emixustat hydrochloride, which is in Phase III clinical stage used for the treatment of stargardt disease, and Phase II clinical stage used for the treatment of proliferative diabetic retinopathy. Kubota Pharmaceutical Holdings Co., Ltd. was founded in 2002 and is headquartered in Minato, Japan.
